Seqens Revenue and Competitors
Estimated Revenue & Valuation
- Seqens's estimated annual revenue is currently $272M per year.
- Seqens's estimated revenue per employee is $196,000
Employee Data
- Seqens has 1388 Employees.
- Seqens grew their employee count by 5% last year.
Seqens's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff - R&D | Reveal Email/Phone |
2 | Head Global Marketing & Business Development CDMO | Reveal Email/Phone |
3 | VP Human Ressources & Industrial | Reveal Email/Phone |
4 | Head Innovation – Pipeline feeding, Process and IP | Reveal Email/Phone |
5 | Head Quality Assurance | Reveal Email/Phone |
6 | Head Innovative Chemical Development | Reveal Email/Phone |
7 | Head Business Development CRDO | Reveal Email/Phone |
8 | Head Europe Sales - Generic APIs | Reveal Email/Phone |
9 | Industrial Project Director | Reveal Email/Phone |
10 | Managing Director | Reveal Email/Phone |
Seqens Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $14.1M | 101 | 5% | N/A | N/A |
#2 | $1.6M | 19 | -71% | N/A | N/A |
#3 | $212.8M | 1063 | 5% | $65M | N/A |
#4 | $6.8M | 54 | 8% | N/A | N/A |
#5 | $12.9M | 92 | 2% | $23.1M | N/A |
#6 | $1M | 12 | N/A | N/A | N/A |
#7 | $106.5M | 599 | -17% | $2.3M | N/A |
#8 | $35.6M | 231 | 6% | N/A | N/A |
#9 | $38.3M | 249 | 5% | N/A | N/A |
#10 | $45M | 299 | -4% | $102.6M | N/A |
What Is Seqens?
SEQENS is an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering unrivalled market responsiveness and tailor-made solutions to our customers. SEQENS operates 24 manufacturing plants and 3 R&D centers in Europe, North America and Asia with 3,200 employees. More than 300 scientists, engineers and experts develop tailor-made solutions for our customers and ensure that products are successfully transferred into production.
keywords:N/A
N/A
Total Funding
1388
Number of Employees
$272M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Seqens News
Symrise, BASF, Ashland, DSM, Seqens, Salicylates and Chemicals, Croda International, Sunjin Beauty Science, Sensient Technologies,...
Global Methyl Silicate Market 2022 Industry Growth Seqens, Drägerwerk AG and Co. KGaA, WACKER, Wilshire Technologies · North America (United...
Increases R&D capability and productivity in the U.S. and builds on merger with CDMO Wavelength Pharmaceuticals. 03.21.22. SEQENS, a manufacturer of active...